Israeli firm gets U.S. nod for advanced trials for non-opiate painkiller

Israeli pharmaceuticals company PainReform has received approval from the U.S. Food and Drug Administration (FDA) to begin late-stage clinical studies for a pain relief drug that is a departure from opiate-based narcotics, it said on Tuesday.

Leave a Reply

Your email address will not be published. Required fields are marked *